deoxypyridinoline has been researched along with olpadronic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomez, AC; Gregorio, S; Mautalen, C; Somoza, J; Zeni, SN | 1 |
| De Grandi, MC; Friedman, S; Gamba, CA; Mandalunis, P; Somoza, J; Tomat, A; Zeni, S | 1 |
2 other study(ies) available for deoxypyridinoline and olpadronic acid
| Article | Year |
|---|---|
Olpadronate prevents the bone loss induced by cyclosporine in the rat.
Topics: Absorptiometry, Photon; Administration, Oral; Alkaline Phosphatase; Amino Acids; Animals; Bone and Bones; Bone Density; Bone Resorption; Cyclosporine; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Drug; Immunosuppressive Agents; In Vitro Techniques; Injections, Intraperitoneal; Male; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2002 |
Changes in bone volume and bone resorption by olpadronate treatment in an experimental model of uremic bone disease.
Topics: Alkaline Phosphatase; Amino Acids; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Calcium; Creatinine; Diphosphonates; Disease Models, Animal; Kidney; Male; Phosphorus; Rats; Uremia | 2005 |